Redoxis is a Swedish CRO with a core competence and experience in preclinical models for autoimmune and inflammatory conditions. We provide a wide range of in vivo and in vitro models validated with standard reference therapies. Our models are excellent tools for investigation of therapeutic efficacy and MoA of novel therapies.Redoxis performs tailor-made preclinical studies combining dedication, experience and agility to provide reliable results to your project.
